Indocyanine green fluorescence angiography enhances surgical planning in laparoscopic low anterior resection for rectal cancer, leading to better patient outcomes. Patients with perfusion risks (older age, higher BMI, neoadjuvant therapy) benefited from ICG-guided plan changes, resulting in significantly higher anastomoses (8.0 cm vs. 6.0 cm, p < 0.001). This group reported superior bowel function with […]
Category: General Surgery
Early Cholecystectomy Lowers Stay in Mild Acute Pancreatitis
Early laparoscopic cholecystectomy in mild acute biliary pancreatitis patients significantly improves outcomes. Early surgery (within 72 hours) cuts hospital stay to 5 days vs. 7 days (p < 0.05). Procedure time is shorter: 61.87 minutes vs. 66.77 minutes (p < 0.05). Implementing early cholecystectomy can streamline surgical workflows without raising complication risks. No differences in […]
Totally laparoscopic pylorus-preserving gastrectomy is safe for early gastric cancer.
Patients undergoing pylorus-preserving surgery had shorter operative times (226 vs. 272 minutes) and shorter hospital stays (9.2 vs. 10.5 days). Higher risk of delayed gastric emptying was noted (12.5% vs. 1.6%). Patients in the pylorus-preserving group showed improved nutritional status and quality of life. Consider pylorus-preserving approaches for selected early-stage cases to enhance postoperative outcomes, […]
Laparoscopic Access Reduces Risks in Right Lobe Liver Tumor Surgery
Laparoscopic retroperitoneal partial hepatectomy offers a safer approach for deep right lobe liver tumors. Complete success in 72 patients; conversion to open surgery in 10 cases. Mean operative time of 140 minutes, with only 150 ml blood loss; average hospital stay was 8.3 days. This technique leads to faster recoveries with fewer complications, making it […]
Flot Outperforms Cross in Esophageal Adenocarcinoma Survival
Flot chemotherapy shows a clear survival advantage over the Cross protocol for esophageal adenocarcinoma, impacting treatment choices. Esopec trial: median overall survival (OS) for Flot at 66 months vs. 37 months for Cross (HR: 0.70, p=0.01). Real-world data: Cross cohort median OS at 33.7 months, with a higher pathological complete response (PCR) of 20.5% versus […]
Neoadjuvant Therapy Duration Impacts Pancreatic Cancer Surgery
Shorter neoadjuvant therapy (≤8 weeks) boosts surgical success in pancreatic cancer. Surgical resection rate significantly higher with ≤8 weeks (66.7%) versus >8 weeks (33.5%). This trend holds for both resectable (73.9% vs 44.7%) and borderline resectable cases (66.4% vs 22.5%). Longer therapy does not improve resection margins or survival, suggesting risks in delaying surgery. No […]
Prognostic Value of C-Reactive Protein-Triglyceride-Glucose Index in Gastric Cancer
Higher levels of the C-reactive protein-triglyceride-glucose index indicate worse outcomes after radical gastrectomy for gastric cancer. Patients with a low cti had significantly longer disease-free survival (DFS) compared to those with high cti. The hazard ratio for high cti predicting poor outcomes is 2.07. Consider using cti and prognostic nutritional index (PNI) for better patient […]
Cryoablation Shows Promise for Locally Advanced Pancreatic Cancer
Cryoablation is a safe and effective treatment for locally advanced pancreatic cancer (LAPC), enhancing patient outcomes when surgery isn’t feasible. No perioperative deaths; smooth surgeries across all patients. Postoperative pancreatic fistulas occurred in 75% of cases, but most were manageable. This technique can prolong survival and improve quality of life by addressing tumor progression directly. […]
Improved Prediction of Lymph Node Metastasis in Pancreatic Cancer
Integrating the neutrophil-albumin ratio with multi-phase CT enhances lymph node metastasis detection in pancreatic cancer patients. A model combining a neutrophil-albumin ratio greater than 0.13 and certain CT findings accurately identifies patients at high risk for lymph node metastasis before surgery. Among 129 patients studied, factors like tumor size and hemangioma thrombosis also showed significant […]
Supportive Care Yields Better Outcomes in Low Rectal Cancer Surgery
Integrating psychosocial, sleep, and nutritional support boosts recovery and survival after low rectal cancer resection. Patients receiving integrated support had a 90.3% disease-free survival at 2 years compared to 79.2% for standard care (p = 0.028). Their overall survival improved to 93.6% vs. 82.5% (p = 0.019). Consider integrating these supportive interventions into surgical practice […]